Search clinical trials for: reference treatment: flupentixol/melitracen

Total 62 results

H. Lundbeck A/S

Completed

Bioequivalence Study to Compare Two Formulations of Deanxit®

Healthy

China
H. Lundbeck A/S

Completed

Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations

Bioequivalence Study in Healthy Subjects

Russian Federation
H. Lundbeck A/S

Completed

Bioequivalence Study in Healthy Men and Women to Compare Two Pharmaceutical Formulations of Flupentixol/Melitracen (Deanxit®)

Healthy Men and Women

United Kingdom
RenJi Hospital

Completed

Compliance With Antidepressant Medication in Treatment of Functional Dyspepsia

Depression | Dyspepsia | Compliance

China
Peking University Third Hospital

Completed

Flupentixol and Melitracen Tablets in the Treatment of Emotional Disorder

Emotional Disorder | Neurologic Disorder

China
RenJi Hospital

Recruiting

The Role of Neuromodulators in Refractory Functional Dyspepsia

Dyspepsia | Functional Gastrointestinal Disorders | Antidepressant Drug Adverse Reaction | Antidepressant Discontinuation Syndrome

China
Mahidol University

Completed

Treatment in Patients With Globus: Psychoeducation, Anxiolytics or Proton Pump Inhibitors

Globus

Thailand
Otsuka Australia Pharmaceutical Pty Ltd

Completed

Refine and Assess the Readability of Patient, Carer, and Clinician Treatment Preference in Myelodysplasia Questionnaire (TPMQ)

Myelodysplastic Syndrome (MDS)

Australia
Assistance Publique - Hôpitaux de Paris
University Hospital, Clermont-Ferrand; Rennes University Hospital; Nantes University...

Unknown

Pulpotomy vs Pulpectomy Outcome. (PULPSAVE)

Inflammatory Pulp Diseases Related to Carious Teeth

France
Chiesi Farmaceutici S.p.A.
Quintiles, Inc.

Completed

Pharmacokinetic Interaction and the Safety of Inhaled CHF5259 and CHF6001

Copd

United Kingdom
Pamukkale University

Completed

Treatment Preferences in Patients With Low Back Pain

Low Back Pain

Turkey
University Children's Hospital Basel
Permamed AG, Switzerland; Galvita AG, Switzerland

Completed

Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg Regular IVERMECTIN Tablets in Healthy Adults Under Fasting Conditions (CHILD-IVITAB)

Bioequivalence

Switzerland
Merck KGaA, Darmstadt, Germany

Completed

Relative Bioavailability of Two Tepotinib Film-Coated Tablet Formulations in Healthy Volunteers

Healthy

Germany
Janssen Infectious Diseases BVBA

Completed

A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants

Healthy | Biological Availability

Netherlands
GlaxoSmithKline

Completed

To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

Skin Care

Brazil
University of Utah

Completed

Improving Decision Role Concordance in Newly Diagnosed Breast Cancer Patients

Breast Cancer
CEN Biotech
medi

Completed

Circaid® Compression Sleeve Versus Short-stretching Bandage in Upper Limb Lymphatic Edema

Lymphedema of Upper Arm

France
Shenzhen TargetRx, Inc.
First Affiliated Hospital Bengbu Medical College

Completed

TGRX-326 Phase I/II Pharmacokinetic Study

Non Small Cell Lung Cancer

China
Janssen Research & Development, LLC

Completed

A Crossover Study to Evaluate the Bioavailability of Ibrutinib Suspension and Sprinkle Formulations Compared to Capsules in Healthy Adults

Healthy

Belgium
Janssen Research & Development, LLC
Pharmacyclics LLC.

Completed

A Study to Assess the Absolute Bioavailability of Oral PCI-32765 and the Effect of Grapefruit Juice on the Bioavailability of PCI-32765 in Healthy Participants

Healthy Volunteer

Belgium
Artromedical Konrad Malinowski Clinic

Recruiting

Posteromedial Tibiofemoral Incongruence (PMTFI) Treatment

Meniscus; Degeneration | Meniscus Lesion | Meniscus Tear | Meniscus Disorder

Poland
Amicus Therapeutics France SAS

Active, not recruiting

Treatment-related Benefit and Satisfaction in Fabry Patients. Insight in Patients Expectations and Preferences

Fabry Disease | Anderson Fabry Disease

France
AstraZeneca

Completed

A Study to Assess the Reaction of Body for Four Different Formulations of AZD9977 (Part A) and Influence of Food and Lower Dose of a Selected Formulation (Part B) in Healthy Male Subjects

Heart Failure

United Kingdom
Janssen Research & Development, LLC

Completed

A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women

Healthy

Belgium
Cerevel Therapeutics, LLC

Recruiting

A Study Evaluating the Pharmacokinetics and Relative Bioavailability of Emraclidine Immediate-Release Tablets in Healthy Adult Participants

Healthy Participants

United States
Jiangxi University of Traditional Chinese Medicine

Active, not recruiting

A Randomized Patient Preference Trial on Heat-sensitive Moxibustion for Primary Hypertension in Community

Primary Hypertension

China
Janssen Research & Development, LLC

Completed

A Study of New Transdermal Contraceptive Patch at End of Shelf Life and Currently Marketed EVRA at the Beginning of Shelf Life in Healthy Women

Healthy

Netherlands, Germany, Belgium
AstraZeneca
Parexel

Completed

A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy Volunteers

Coronary Artery Disease (CAD)

United Kingdom
University Hospital, Clermont-Ferrand

Completed

Levobupivacaine for Epidural Analgesia in Labour

Analgesia, Epidural
Ukrainian Medical Stomatological Academy

Completed

Effects of Azithromycin as an Adjunct to Scaling and Root Planning in the Treatment of Periodontitis

Periodontitis

Ukraine
Columbia University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

COPES Phase I Randomized Controlled Trial of Treatment For Distress in Heart Disease Patients

Depression | Heart Diseases

United States
University Hospital, Brest

Completed

Stress Factors Induced by Patient and Young Clinicien During Endodontic Treatment (STRESSENDO)

Endodontic Treatment

France
Janssen-Cilag, S.A.

Completed

A Study to Assess the Clinical Profile of Patients in Spain With Moderate to Severe Psoriasis.

Psoriasis
Hackensack Meridian Health

Recruiting

Quit & Fit 2.0: Feasibility and Usability Testing

Smoking Cessation

United States
Memorial Sloan Kettering Cancer Center

Completed

A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery

Cutaneous Melanoma

United States
Duke University
National Center for Complementary and Integrative Health (NCCIH); University... and other collaborators

Active, not recruiting

Improving Veteran Access to Integrated Management of Back Pain (AIM-BACK)

Low Back Pain | Veterans Family

United States
Actavis Inc.

Completed

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed Conditions

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study of Canagliflozin and Metformin Immediate Release (50 mg/500 mg) FDC Tablets in Healthy Volunteers

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study of Canagliflozin and Metformin Immediate Release (150 mg/500 mg) FDC Tablets in Healthy Volunteers

Healthy

United States
Janssen Research & Development, LLC

Completed

A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Neoplasms

United States, Spain, Canada, Belgium
Case Comprehensive Cancer Center

Completed

Feasibility of a Team Approach for Discussing Prognosis and Treatment Goals in Breast Cancer

Advanced Breast Cancer | Recurrent Breast Cancer | Stage 4 Breast Cancer

United States
Pierre Fabre Medicament

Completed

Nicotine Patch - Bioequivalence Study

Healthy Smokers

France
Actavis Inc.

Completed

Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on Applesauce

Healthy

United States
Actavis Inc.

Completed

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed Conditions

Healthy

United States
Actavis Inc.

Completed

Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting Conditions

Healthy

United States
Actavis Inc.

Completed

Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted Conditions

Healthy

United States
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Bioequivalence of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared With Clarityne Tablets

Healthy

China
Pierre Fabre Medicament

Completed

Nicotine Patch Bioequivalence Study

Healthy Smokers

France
Pierre Fabre Medicament

Completed

Nicotine Patch - Multidose Bioequivalence Study

Healthy Smokers

France
Xian-Janssen Pharmaceutical Ltd.

Completed

A Study to Assess the Relative Bioavailability of Xisimin (Loratadine) Tablets Under Fasting and Fed Conditions in Healthy Participants Compared to Clarityne Tablets

Healthy

Taiwan

3

Subscribe